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BACKGROUND AND PURPOSE
Na+/HCO3- co-transport (NBC) regulates intracellular pH (pHi) in the heart. We have studied the electrogenic NBC isoform
NBCe1 by examining the effect of functional antibodies to this protein.
EXPERIMENTAL APPROACH
We generated two antibodies against putative extracellular loop domains 3 (a-L3) and 4 (a-L4) of NBCe1 which recognized
NBCe1 on immunoblots and immunostaining experiments. pHi was monitored using epi-fluorescence measurements in cat
ventricular myocytes. Transport activity of total NBC and of NBCe1 in isolation were evaluated after an ammonium ion-
induced acidosis (expressed as H+ flux, JH, in mmol·L-1 min-1 at pHi 6.8) and during membrane depolarization with high
extracellular potassium (potassium pulse, expressed as DpHi) respectively.
KEY RESULTS
The potassium pulse produced a pHi increase of 0.18 6 0.006 (n = 5), which was reduced by the a-L3 antibody (0.016 6
0.019). The a-L-3 also decreased JH by 50%. Surprisingly, during the potassium pulse, a-L4 induced a higher pHi increase
than control,(0.25 6 0.018) whereas the recovery of pHi from acidosis was faster (JH was almost double the control value).
In perforated-patch experiments, a-L3 prolonged and a-L4 shortened action potential duration, consistent with blockade
and stimulation of NBCe1-carried anionic current respectively.
CONCLUSIONS AND IMPLICATIONS
Both antibodies recognized NBCe1, but they had opposing effects on the function of this transporter, as the a-L3 was
inhibitory and the a-L4 was excitatory. These antibodies could be valuable in studies on the pathophysiology of NBCe1 in
cardiac tissue, opening a path for their potential clinical use.
Abbreviations
bi, intrinsic buffering capacity; AE1, Cl-/HCO3- exchanger isoform 1; AE3, Cl-/HCO3- exchanger isoform 3; a-L3,
antibody against putative extracellular loop domain 3 of NBCe1; a-L4, antibody against putative extracellular loop
domain 4 of NBCe1; AP, cardiac action potential; APD, action potential duration; BCECF, 2′,7′-Bis-(2-carboxyethyl)-5,6-
carboxyfluorescein; CAII, carbonic anhydrase II; DIDS, 4,4′-diisothiocyanatostilbene-2,2′-disulphonic acid; EC3,
extracellular loop 3; EC4, extracellular loop 4; eNBC, electrogenic Na+/HCO3- co-transporter; GST, glutathione
S-transferase; NBC, Na+/HCO3- co-transporter; NBCe1, electrogenic Na+/HCO3- co-transporter isoform 1; NBCe2,
electrogenic Na+/HCO3- co-transporter isoform 2; NBCn1, electroneutral Na+/HCO3- co-transporter isoform 1; NHE,
Na+-H+ anti-porter; N-I serum, non-immune serum; nNBC, electroneutral Na+/HCO3- co-transporter; pHi, intracellular
pH; SITS, 4-acetamido-4-isothiocyanatostilbene-2,2′-disulphonic acid
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Introduction
Intracellular pH (pHi) modulates excitation and contraction
in the heart (Bountra and Vaughan-Jones, 1989; Bers, 2001).
Ion transporters facilitate the fine control of cardiac pHi and
attenuate the adverse effects of large changes in pHi
(Vaughan-Jones et al., 2009). The major transporters respon-
sible for acid extrusion are the Na+-H+ anti-porter (NHE) and
Na+-HCO3- co-transporters (NBC), which transport H+ out of
and HCO3- into the cell respectively (Dart and Vaughan-
Jones, 1992; Karmazyn and Moffat, 1993). In the absence of
HCO3-, the only acid extruding mechanism is the widely
studied NHE. In medium with bicarbonate, like the blood,
both mechanisms, NHE and NBC, are equally operative at a
pHi close to basal (Lagadic-Gossmann et al., 1992; Camilion
de Hurtado et al., 1995; Le Prigent et al., 1997; Vaughan-Jones
et al., 2006; 2009).
Distinct NBC isoforms coexist in the mammalian myocar-
dium, the electrogenic isoforms, NBCe1 (or NBC1) (Romero
et al., 1997; Choi et al., 1999) and NBCe2 (or NBC4) (Pushkin
et al., 2000; Virkki et al., 2002), with a stoichiometry of
1 Na+:2 HCO3-, and the electroneutral isoform NBCn1 (or
NBC3), with a stoichiometry of 1 Na+:1 HCO3-. The electro-
genic NBCe1 and NBCe2 are encoded by the SLC4A4 gene
(Choi et al., 1999), and the SLC4A5 gene (Pushkin et al., 2000;
Sassani et al., 2002), respectively, while NBCn1 is encoded by
the SLC4A7 gene (Choi et al., 2000). In our laboratory, we
have determined the influence of the electrogenic NBC
(eNBC) in the configuration of the rat and cat ventricular
action potential (AP), generating an anionic repolarizing
current, which produces an AP shortening of approximately
25% (Aiello et al., 1998; Villa-Abrille et al., 2007). The electro-
genic isoform involved in this effect was not, however, deter-
mined in our previous studies.
In the present study, we focus our attention on NBCe1, by
examining the effect of isoform-specific antibodies. These
polyclonal antibodies were produced in rabbits injected with
fusion proteins, containing the amino-acid sequence of the
extracellular loop 3 (EC3) and extracellular loop 4 (EC4) of
the putative topological structure of NBCe1 (Alvarez et al.,
2003). As these antibody epitopes are localized on the extra-
cellular side of NBCe1, we hypothesized that antibodies selec-
tively directed against them could be able to interfere with
NBCe1 transport function and therefore, might be employed
as pharmacological tools. Herein, we present evidence for
inhibition and stimulation of NBCe1 transport activity with
antibodies selectively directed against EC3 (a-L3) and EC4
(a-L4), respectively, validating our hypothesis.
Methods
Glutathione-S-transferase (GST) fusion
protein construction
Bacterial expression constructs encoding GST-fusion protein
consisting of the cDNA for GST fused to cDNA corresponding
to the third (EC3) or fourth (EC4); putative extracellular loops
of human NBCe1 were constructed as previously described
(Alvarez et al., 2003).
Protein expression
Expression constructs for NBCe1b, the human cardiac splic-
ing variant of NBCe1 (Alvarez et al., 2003) and human
NBCn1 (Loiselle et al., 2003), have been described previously.
Expression construct for rat NBCe2 (NBC4c) was a gift from
Dr Jeppe Praetorius (Aarhus University, Denmark). Human
HEK293 cells were individually transfected with NBCe1b,
NBCe2 or NBCn1, as indicated, using the calcium phosphate
method (Ruetz et al., 1993). Cells were grown at 37°C in an
air/CO2 (19:1) environment in Dulbecco’s modified Eagle’s
medium supplemented with 10% (v/v).
Antibody preparation
All animal care and experimental procedures complied with
the Guide for the Care and Use of Laboratory Animals pub-
lished by the US National Institutes of Health (NIH Publica-
tion no. 85-23, revised 1996). Male New Zealand rabbits
(San Cayetano, Monte Grande, Buenos Aires, Argentina)
(3 months old) were immunized subcutaneously with 1 mg
of fusion protein in Freund’s complete adjuvant followed by
a twice immunization at monthly intervals with 1 mg of
fusion protein in Freund’s incomplete adjuvant. The animals
were exsanguinated, and crude sera with the designated anti-
bodies anti-NBCe1 loop 3 (a-L3) and anti-NBC1 loop 4 (a-L4),
respectively, were obtained. Freund’s complete adjuvant
without fusion protein was injected to rabbits to generate
non-immune serum (N-I serum).
Immunodetection
Two days post-transfection, cells were washed in PBS buffer (in
mmol·L-1: 140 NaCl, 3 KCl, 6.5 Na2HPO4, and 1.5 KH2PO4,
pH 7.5) and cell lysates were prepared by the addition of
150 mL SDS-PAGE sample buffer to 60 mm Petri dish. Samples
of untransfected or transfected HEK293, or samples of cat
ventricular lysates (50 mg protein), were resolved by SDS-PAGE
on 7.5 acrylamide gels. Proteins were transferred to PVDF
membranes, and then incubated with rabbit anti-NBC1 anti-
body (Millipore, Temecula, CA, USA; 1:1000 dilutions), rabbit
anti-NBCe1 loop 3 (a-L3) antibody (1:500 dilutions), rab-
bit anti-NBCe1 loop 3 (a-L4) antibody (1:500 dilutions), rabbit
anti-NBCe2 antibody (ab99131 Abcam, Cambridge, MA, USA;
1:2000 dilutions), rabbit anti-NBCn1 antibody (1:2000 dilu-
tions) (Loiselle et al., 2003) or N-I serum (1:500 dilutions).
Membranes were blocked with 5% non-fat milk. Immunoblots
were incubated with donkey anti-rabbit IgG conjugated to
horseradish peroxidase and visualized using the ECL reagent
and a Chemidoc Image Station (Bio-Rad, Hercules, CA, USA).
To demonstrate the specificity of the immunoreactivity,
duplicate samples were submitted to the same protocol
except that the primary antibody was incubated for 1 h in the
presence of the EC3 and EC4 fusion proteins (1 mg ml-1 final
concentration) used to generate the antiserum.
Preparation of ventricular myocytes
Cat ventricular myocytes (San Cayetano, Monte Grande,
Buenos Aires, Argentina) were isolated according to the tech-
niques previously described (Aiello and Cingolani, 2001).
pHi measurements
pHi was measured in single myocytes with an epi-fluorescence
system (Ion Optix, Milton, MA, USA), using the 2′,7′-Bis-(2-
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carboxyethyl)-5,6-carboxyfluorescein (BCECF) technique, as
previously described (De Giusti et al., 2008). Briefly, myocytes
were incubated at room temperature for 30 min with
10 mmol·L-1 BCECF-acetoxymethylester followed by 30 min
washout. Dye-loaded cells were placed in a chamber on the
stage of an inverted microscope (Nikon TE 2000-U, Nikon,
Tokyo, Japan) and continuously superfused with a solution,
containing (mmol·L-1) 5 KCl, 118 NaCl, 1.2 MgSO4, 0.8 Cl2Mg,
1.35 Cl2Ca, 10 glucose, 20 NaHCO3, pH 7.4 after continuous
bubbling with 5% CO2 and 95% O2. The myocytes were
stimulated via two-platinum electrodes on either side of the
bath at 0.5 Hz. Dual excitation (440 and 495 nm) was pro-
vided by a 75 W xenon arc lamp and transmitted to the
myocytes. Emitted fluorescence was collected with a photo-
multiplier tube equipped with a band-pass filter centred at
535 nm. The 495 to 440 nm fluorescence ratio was digitized at
10 kHz (ION WIZARD fluorescence analysis software, IonOtix,
Milton, MA, USA). At the end of each experiment, the fluo-
rescence ratio was converted to pH by calibrations using the
high K+-nigericin method (Perez et al., 1995).
Ammonium pulse
As described previously, the experiments were performed in
HCO3- buffered solution. Under these conditions, both pHi
alkalinizing systems are operative, NHE and NBC. In order to
examine only the NBC activity, all the experiments were
performed in the presence of the NHE inhibitor HOE642
(cariporide; 10 mmol·L-1). Total NBC activity was assessed by
evaluating the pHi recovery from an ammonium pre-pulse-
induced acute acid load. Transient (3 min) exposure of myo-
cytes to 20 mmol·L-1 NH4Cl was used for this purpose. The
dpHi/dt at each pHi, obtained from an exponential fit of the
recovery phase, was analysed to calculate the net H+ efflux
(JH), then JH = btot dpHi/dt, where btot is total intracellular
buffering capacity. btot was calculated by the sum of the intra-
cellular buffering due to CO2 (bCO2) plus the intrinsic buffering
capacity (bi). bCO2 was calculated as bCO2 = 2.3 [HCO3-]i, where
[HCO3-]i = [HCO3-]o 10pHi–pHo (Leem et al., 1999; Roos and
Boron, 1981). bi of the myocytes was measured by exposing
cells to varying concentrations of NH4Cl in Na+-free HEPES
bathing solution. pHi was allowed to stabilize in Na+-free
solution before application of NH4Cl. bi was calculated from
the equation bi = D[NH4+]i/DpHi and referred to the mid-point
values of the measured changes in pHi. bi at different levels of
pHi was estimated from the least squares regression lines bi
versus pHi plots (Supporting Information Figure S1).
Potassium pulse
To investigate the eNBC activity in isolation, we performed a
potassium pulse. Increasing isotonically extracellular K+ [K+]o
from 5 to 45 mmol·L-1 produced a depolarization of approxi-
mately 60 mV that enhanced the eNBC activity and in turn
elevated pHi. The high K+ was applied for 14 min and during
this period the pHi was recorded. The HCO3--buffered solu-
tion used in the K+-induced depolarization experiments con-
tained (mmol·L-1): 118 NaCl, 5 KCl, 1 MgSO4, 0.35 NaH2PO4,
10 glucose, 40 choline chloride, 20 NaHCO3, pH 7.4 after
continuous bubbling with 5% CO2 and 95% O2. K+-induced
depolarization was assessed by replacing 40 mmol·L-1 choline
chloride with 40 mmol·L-1 KCl, maintaining ionic strength.
Immunostaining of cat cardiac myocytes and
analysis by confocal microscopy
Freshly single dissociated adult cat myocytes were plated onto
22 ¥ 22 mm laminin (30 mg mL-1)-coated glass coverslips and
incubated at 37°C for 45 min to allow attachment. Cells were
rinsed with PBS and fixed in 4% (w/v) paraformaldehyde for
15 min at room temperature, followed by methanol fixation-
permeabilization [ice-cold 100% (v/v) methanol, 5 min at
-20°C]. Myocytes were then washed with PBS and permeabi-
lized with 0.1% Triton X-100 (v/v) in PBS for 15 min at room
temperature. After washing (2 ¥ 5 min with PBS) and blocking
(5% BSA in PBS, 20 min) were completed, the cells were
incubated with primary antibodies (1 h at room temperature,
in a humidified chamber), washed (3 ¥ 5 min in PBS contain-
ing 0.2% gelatin) and incubated with secondary antibody.
Primary rabbit polyclonal a-L3, rabbit polyclonal a-L4 anti-
body and N-I serum were used at 1:100 dilution. Secondary
chicken anti-rabbit conjugated to Alexa fluor 488 was used at
1:200 dilutions. Coverslips were washed three times in PBS
containing 0.2% gelatin and twice in PBS, and mounted and
viewed with a confocal microscope. Immunostained cells
were mounted in Prolong anti-fade solution (Molecular
Probes, Eugene, OR, USA) and imaged with an Olympus Bx61
laser scanning confocal microscope imaging system. Images
were collected with an oil immersion ¥60 1.4 objective
(numerical aperture 0.2, plan Apochromat, Zoom 1.5¥).
Images were captured in a sequential manner, and analyzed
with the Fluoview 3.3 Software (Olympus, Madison, WI, USA).
Double immunostaining of cat
cardiac myocytes
Isolated adult cat cardiomyocytes were fixed to laminin-
coated coverslips and permeabilized as described above. Myo-
cytes were incubated with a combination of a-L3 antibody
and goat polyclonal anti-vinculin antibody (N-19; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), or a combination of
rabbit a-L4 antibody and goat anti-vinculin antibody. Com-
bined primary antibodies were used at 1:100 dilutions. Sec-
ondary chicken anti-rabbit conjugated to Alexa Fluor 488 and
chicken anti-goat conjugated to Alexa fluor 594 was used at
1:200 dilutions. Images were captured and analysed as
explained previously.
Patch-clamp recordings
The nystatin-perforated whole-cell configuration of the
patch-clamp technique was used for current-clamp record-
ings with a patch-clamp amplifier (Axopatch 200A, Axon
Instruments, Foster City, CA, USA). Patch pipettes were pulled
with a PP-83 puller (Narishige, Tokyo, Japan) and fire pol-
ished with an MF-83 Microforge (Narishige) to a final resis-
tance of 0.5–1 MW when filled with a control pipette
solution. Membrane voltage (sampling rate = 1 kHz; low pass
filter = 1 kHz) was digitally recorded directly to hard disc via
an analog-to-digital convertor (Digidata 1200, Axon Instru-
ments) interfaced with a computer running pClamp software
(Axon Instruments). A pacing rate of 0.2 Hz was applied. Data
analysis was performed with pClamp (Clampfit, Axon Instru-
ments). An Ag/AgCl wire directly in contact with the extra-
cellular solution was used as reference electrode. As the
pipette potential was nulled in external solution, all current-
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clamp tracings required corrections for junction potential.
This was accomplished by filling 20 pipettes with standard
internal solution. They were then nulled in internal solution,
and the difference in potential on immersion in external
solution was recorded. The measured junction potential
value was consistently -10 mV, and this value was used to
correct all current-clamp data and voltage-clamp protocols.
There were no significant differences in the value of junction
potential among all the external solutions used in the present
work. Bath solution was the same as that used for the pHi
measurements in the ammonium pulse experiments. The
nystatin pipette solution contained (in mmol·L-1): K glucon-
ate 130, KCl 10, NaCl 5, MgCl2 0.5, EGTA 1, HEPES 10 and
nystatin 0.3 mg ml-1. The pH was titrated to 7.2 with KOH.
Statistics
Data were expressed as means 6 SEM and were compared
with Students’s t-test or One-way ANOVA followed by Student–
Newman–Keuls post hoc test. A value of P < 0.05 was consid-
ered statistically significant (two-tailed test).
Materials
BCECF (Invitrogen, Buenos Aires, Argentina) HOE642 S0859
(Sanofi-Aventis, Frankfurt, Germany).
Results
Expression and localization of NBC1 in
cat myocardium
Expression of Na+/HCO3- co-transporters NBCe1, NBCn1 and
NBCe2 has been previously observed in heart tissue (Choi
et al., 1999; Pushkin et al., 1999; 2000). Expression of NBCe1
protein has been documented in mammalian heart (Khan-
doudi et al., 2001). Expression of NBCn1 and NBCe2, however,
has only been detected at the mRNA level in the heart, using
Northern blot and reverse transcription RT-PCR analysis (Ish-
ibashi et al., 1998; Pushkin et al., 1999; Choi et al., 2000). We
examined the expression of NBCe1 protein in the cat myocar-
dium, using different antibodies. Antibodies were raised
against fusion proteins corresponding to putative third (EC3)
and fourth (EC4) extracellular loops of human NBCe1 and
used to detect NBCe1 in isolated ventricles of cat heart. Amino
acid sequence alignment of human sequences of SLC4 family
members, AE and NBC families, are presented in Figure 1A.
The alignments of putative EC3 and EC4 regions of bicarbon-
ate transport proteins, although showing clusters of conserved
sequence, present enough non-conserved amino acids to con-
stitute dissimilar antigen determinant regions, minimizing
the risk of inducing the generation of antibodies that could
produce cross-reaction between the different transporters.
Immunoblots of cat ventricles, probed using a specific com-
mercial anti-NBCe1 antibody (Millipore; Figure 1B), a-L4
(Figure 1C) and a-L3 (Figure 1D) demonstrated a band with a
molecular mass of ~130 kDa, corresponding to NBCe1 (Alvarez
et al., 2003). A band with a similar molecular mass was
detected in lysates of HEK293 cells transfected with NBCe1
used as controls (Figure 1B–D). Cat cardiac NBCe1 appears to
be slightly larger than NBCe1 transfected in HEK293 cells,
possibly due to glycosylation of the protein in myocardium.
No immunoreactivity was found in non-transfected HEK293
cells (Figure 1B–D), or on parallel blots incubated with non-
immune serum (N-I serum) (Figure 1E). Other non-specific
bands were detected with the commercial anti-NBCe1, as well
as with the serum containing a-L3 or a-L4. We did not perform
additional assays to investigate this matter. The existence of
different oligomeric (dimeric, tetrameric) states of NBCe1 in
transfected HEK293 cells has been demonstrated before (Kao
et al., 2008). A single band of approximately 250 kDa is
observed in lysates of NBCe1-transfected cells (Figure 1D),
which may therefore represent a dimer.
As EC3 and EC4 loops of NBCe1 share some amino acid
identity with homologous regions in other NBC proteins
(Figure 1A) and NBCe2 and NBCn1 gene products are also
proposed to be expressed in mammalian cardiac myocytes, it
is essential to establish the selectivity of a-L3 and a-L4 for
NBCe1. Figure 2A shows that a-L3 or a-L4 failed to detect
NBCn1 (135 kDa) or NBCe2 (126 kDa) in lysates of HEK cells
transfected with these NBC isoforms on immunoblots. Using
specific antibodies against these NBC isoforms, we confirmed
in parallel blots that the HEK cells used in Figure 2A were
efficiently transfected with NBCn1 or NBCe2 (Figure 2A,
inset). Note that an immunoreactive band is present in
lysates of non-transfected HEK cells, suggesting that NBCn1 is
endogenously expressed in these cells (Figure 2A, inset).
To determine whether the a-L3 or a-L4 sera specifically
target the EC3 or EC4 loops of NBCe1, we performed compe-
tition experiments. These sera were co-incubated with the
GST fusion proteins used to generate them. As shown in
Figure 2B, the fusion proteins pre-adsorbed immunoreactiv-
ity from a-L3 and a-L4, because no band corresponding to
NBCe1 was detected in lysates of NBCe1-transfected HEK cells
on immunoblots probed with the fusion-protein pre-
adsorbed sera.
Other members of the SLC4 family, AE1 and AE3, have
been localized to the sarcolemma (SL), and to the SL and
T-tubules system of cardiomyocytes respectively (Alvarez
et al., 2007). In order to study the localization of NBC1, we
performed confocal microscopy studies. Antibodies against
NBCe1 revealed labelling surrounding the cat isolated cardi-
omyocytes, consistent with sarcolemmal staining (Figure 3A).
In addition, NBCe1 staining shows intracellular localization,
with invaginations that run towards the centre of the cardi-
omyocytes. Such a distribution is consistent with the pres-
ence of NBCe1 in the sarcolemma and along the transverse
tubular system (T-tubules), as suggested by the longitudinal
bands. No immunolabelling was seen with the N-I serum, in
isolated cat cardiomyocytes (Figure 3A).
The identity of the intracellular structures containing
NBCe1 was further explored in double-labelling experiments
of freshly isolated cat cardiomyocytes (Figure 3B). NBCe1
protein was found with transverse rib-like pattern, suggesting
specific location of this protein in the T-tubules, an invagi-
nation of the SL at the level of the Z band, extending
deep into the cardiomyocytes. NBCe1 showed intense
co-localization with vinculin, a cell-matrix focal adhesion
molecule present in the T system, as observed in the merged
image (yellow, Figure 3B).
We conclude that the electrogenic NBCe1 protein was
expressed in cat heart muscle, as detected by immunoblots.
NBCe1 has a restricted pattern of localization in isolated cat
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cardiomyocytes, being specifically localized to SL and
T-tubules. On the basis of its function and localization, a
fundamental role for NBCe1 in cardiomyocytes excitation–
contraction coupling is possible.
Determination of eNBC activity with the
potassium pulse
Myocytes were exposed to a high extracellular K+ solution
(45 mmol·L-1) to induce hyperkalemic depolarization of
membrane potential, which resulted in an alkalization that
was reversed upon washout of the high K+ solution
(Figure 4A). Analysis of these experiments revealed that this
increase in pHi was blocked by pretreatment of the cells with
the recently reported NBC blocker S0859 (Ch’en et al., 2008),
but not by the NHE inhibitor HOE642, indicating that this
effect is mediated by selective activation of eNBC (Figure 4B).
To evaluate further the specificity of the depolarization assay
to determine eNBC activity, experiments in the absence of
sodium or bicarbonate were performed. The pHi increases
induced by the high extracellular K+ solution were abolished
by removing Na+ and HCO3- (Supporting Information Figure
S2), indicating that the pHi changes arose from the electro-
chemical activation of eNBC.
The enzyme carbonic anhydrase II (CAII) carries rapid
CO2/HCO3- interconversion and facilitates membrane
NBCe1-mediated HCO3- transport (Alvarez et al., 2003). Inhi-
bition of CAII is commonly achieved with sulphonamides
or their derivatives. However, recently, some non-
sulphonamides, such as HOE642, have been reported to
inhibit the enzyme (Villafuerte et al., 2007). In our experi-
ments, HOE642 did not affect maximal NBCe1-mediated
alkalization after high potassium depolarization, although it
Figure 1
Alignment of amino acid sequences of bicarbonate transport proteins and expression of NBCe1 protein in cat ventricles. (A) Alignment of amino
acid sequences of bicarbonate transporter EC3 and EC4. Sequence conservation is indicated by black rectangles (identical amino acids) and grey
rectangles (similar amino acids). Pink colour indicates EC3 and EC4 loops predicted from AE1 (Tang et al., 1999; Zhu et al., 2003). Orange colour
indicates amino acids used for a-L3 and a-L4 construction. (B–E) Lysates of HEK293 cells; HEK293 cells transfected with NBCe1 or cat ventricles
(50 mg) were resolved by SDS-PAGE on 8% polyacrylamide gels, transferred to PVDF membrane and probed for NBC1 with a commercial antibody
against NBC1 N-terminus (amino acids 338–391) (B), a-L3 (C), a-L4 (D) or N-I serum (E). Position of NBCe1 is indicated with arrowheads.
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did slow the time-course of alkalization achieved by NBCe1.
For CAII, the IC50 values for HOE642 are 12.4 mmol·L-1 and
60 mmol·L-1, for pure CAII or cardiac CA homogenate, respec-
tively (Villafuerte et al., 2007), which are in the range of the
dose we have used here (10 mmol·L-1). Thus some inhibition
of NBCe1-mediated HCO3- -transport by this drug may there-
fore be secondary to inhibition of CAII.
Opposing functional effects of a-L3 and a-L4
on NBCe1 activity evaluated with the
potassium pulse
Effects of the antibodies against extracellular loops of NBCe1
were evaluated with the potassium pulse approach in isolated
cat cardiomyocytes. The potassium pulse produced a control
(N-I serum dilution 1/500) pHi increase of 0.18 6 0.01 pH
units (n = 5) that was abolished by the a-L3 (serum dilution
1/500), indicating that NBCe1 is the predominant functional
electrogenic NBC present in cat ventricular myocytes
(Figure 5). Surprisingly, during the potassium pulse, the a-L4
(serum dilution 1/500) induced a higher pHi increase than
control (Figure 5). This stimulatory effect of a-L4 was not
produced in the absence of sodium or bicarbonate or in the
presence of S0859 (Supporting Information Figure S3), reveal-
ing a specific action on NBCe1.
In order to confirm that a-L3 or a-L4 sera did not exert
non-specific effects, we performed functional competition
Figure 2
Detection of human Na+/HCO3- co-transporter NBCe1 protein in membrane preparations from HEK293 cells. Cell lysates were prepared from
untransfected HEK293 cells or HEK293 cells individually transfected with NBCe1, NBCn1 or NBCe2 cDNA. Proteins were resolved by SDS-PAGE
and then detected by immunoblotting. Blots were pre-incubated with a-L3 or a-L4 antiserum (final dilution 1:500) either in absence (A) or
presence (B) of soluble NBCe1 fusion proteins (final concentration 1 mg ml-1) used to generate antisera, followed by incubation with donkey
anti-rabbit IgG conjugated with horseradish peroxidase (HRP). Inset blots (above) were pre-incubated with a-NBCn1 antibodies (left, 1:2000), or
pre-incubated with a-NBCe2 antibodies (right, 1:2000) followed by HRP-conjugated donkey anti-rabbit antibodies. Labelled proteins were
detected by enhanced chemiluminescence. Positions of pre-stained molecular mass markers are indicated at left.
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experiments, using sera incubated with the immunogenic
fusion proteins (containing the sequences of the EC3 or EC4
loops). The effects of both antibodies on NBCe1 activity were
evaluated in the presence of the respective fusion proteins
(Figure 5C). Under these conditions, the inhibitory action of
a-L3 and the stimulatory effect of a-L4 were blocked, indicat-
ing that removal of anti-EC antibodies removed the action
from the sera.
Dose-response curves of the effect of a-L3 (Figure 6A) and
a-L4 (Figure 6B) on the NBCe1 transport activity showed that
the serum concentration containing a-L3 or a-L4 used in the
experiments of Figure 5 (1/500) produced maximal responses
on NBCe1 activity.
Opposing functional effects of a-L3 and a-L4
on NBCe1 activity evaluated with the
ammonium pulse
We have recently studied the participation of NBC in pHi
recovery, after acidification induced by the ammonium pulse
in cat isolated ventricular myocytes (De Giusti et al., 2009). In
order to assess the differential activity of NBCe1 in this pHi
recovery, we pre-incubated the cells 10 min before an ammo-
nium pulse with the a-L3 or a-L4 (1/500 dilutions). These
experiments were performed in the continuous presence of
10 mmol·L-1 HOE642, in order to eliminate the participation
of the NHE during the recovery of pHi. The a-L3 decreased
and the a-L4 increased the NBC-mediated JH in comparison
with N-I serum (control), indicating that NBCe1 contributed
to pHi recovery from acidosis in cat ventricular myocytes
(Figure 7). The effects of a-L3 and a-L4 were also evaluated in
the ammonium pulses in the absence of HCO3- and HOE642
(Supporting Information Figure S4). Under these conditions,
no effects were observed, indicating that these sera exert their
effects on a bicarbonate-dependent alkalinizing mechanism
without affecting the activity of NHE.
The inhibitory effect of a-L3 is supported by previous
results from Khandoudi et al. (2001), who also found that a
polyclonal antibody directed against a short sequence of
NBCe1 EC3 region slowed pHi recovery from acidosis in rat
ventricular myocytes (Khandoudi et al., 2001). The previous
study did not, however, examine the rat cardiac NBCe1 activ-
ity in isolation. Nevertheless, taken together, these experi-
ments suggest that these antibodies might represent a useful
tool to functionally discriminate the transport activity of
NBC isoforms.
Opposing functional effects of a-L3 and
a-L4 on NBCe1 activity evaluated with
perforated patch
We have recently demonstrated that eNBC contributes to the
normal configuration of the AP waveform of cat ventricular
myocytes (Villa-Abrille et al., 2007). We reported that chang-
Figure 3
Localization of NBCe1 in cat ventricular myocytes. Confocal immunofluorescence analysis of the distribution of NBCe1 in cat myocytes. (A) Freshly
isolated cat cardiomyocytes were stained with rabbit a-L3 antibody, or rabbit a-L4, or non-immune serum, as indicated in the panels. Images were
collected with an Olympus Bx61 laser-scanning confocal microscope, with an oil immersion ¥60/1.4 objective. Scale bars are 30 mm. (B) cat
cardiomyocytes were double-stained with rabbit a-L4 (green) and goat anti-vinculin antibody (red), as indicated in the panels. Immunofluores-
cence signals were visualized by an Alexa fluor 488-conjugated anti-rabbit IgG antibody (green, 1:200 dilution), and Alexa fluor 594-conjugated
anti-goat IgG antibody (red, 1:200 dilution). Co-localization of NBCe1 and vinculin is indicated as merge and with yellow staining. DICM,
differential interference contrast microscopy. Bar = 30 mm.
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ing the superfusate bathing myocytes from a HCO3--free
(HEPES buffer) to a HCO3--containing solution at constant
pHo, induces 15–25% shortening of AP duration (APD), con-
sistent with the influx of HCO3- into the cell. These changes
were sensitive to the extracellular concentration of HCO3-
and were blunted by anionic blockade or by sodium depriva-
tion (Villa-Abrille et al., 2007). In the present work, we evalu-
ated the participation of NBCe1 in this eNBC-mediated APD
shortening. We examined APs recorded in HCO3--containing
solution at constant pHo, before and after exposing the myo-
cytes to N-I serum, serum containing a-L3 or serum contain-
Figure 4
Isolation of the eNBC activity with the potassium pulse. (A) Repre-
sentative traces of pHi recorded from myocytes exposed to the
potassium pulse in control and in the presence of the NHE blocker
HOE642 (10 mmol·L-1) or the NBC blocker S0859 (10 mmol·L-1). (B)
Average data of pHi alkalinization induced by the high potassium-
induced depolarization of membrane potential in control (n = 6) and
in the presence of the inhibitor of NHE, HOE642 (10 mmol·L-1, n = 7)
or the inhibitor of NBC, S0859 (10 mmol·L-1, n = 5). Data are
expressed as increase of pHi units in comparison with the zero time
point in high potassium solution. *P < 0.05 significantly different
from control and HOE642.
Figure 5
Effects of a-L3 and a-L4 on NBCe1 activity evaluated with the potas-
sium pulse. (A) Representative traces of pHi recorded from myocytes
exposed to the potassium pulse in the presence of the N-I serum
(1:500), a-L3 (1:500) or a-L4 (1:500). (B) Average time course of the
increase in pHi elicited by 14 min exposure to high potassium in the
absence (N-I serum, 1:500, n = 5) and presence of a-L3 (1:500, n =
5) or a-L4 (1:500, n = 6). Data are expressed as increase of pHi units
in comparison with the zero time point in high potassium solution.
*P < 0.05 significantly different from N-I serum. (C) Average data
obtained after 14 min of myocyte exposure to N-I serum (n = 5) or
serum with a-L3 (n = 4) or a-L4 (n = 4) co-incubated with the fusion
proteins (1 mg ml-1, 1 h co-incubation), containing the sequences of
the EC3 or EC4 loops.
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ing a-L4 (Figure 8A). Whereas N-I serum had no effect on
APD, a-L3 prolonged and a-L4 shortened APD, as expected
from the effects of these antibodies in the experiments of pHi
measurements. Analysis of averaged data showed that serum
containing a-L3 induced an APD lengthening (measured at
90% of repolarization time, APD90) of approximately 17%,
consistent with blockade of NBCe1. In contrast, serum con-
taining a-L4 induced an average APD90 shortening of almost
20%, according to stimulation of NBCe1 (Figure 8B). Parallel
experiments performed in the absence of HCO3- (HEPES-
buffered solution) demonstrated that the antibodies did not
exert significant effects (Supporting Information Figure S5),
suggesting that they do not affect currents other than that
generated by NBCe1. During the recordings of APs in the
presence of bicarbonate, it is possible that the selective action
of the antibodies on NBCe1 could affect pHi and therefore
modify channel activity and APD. However, this possibility
seems very unlikely as the changes in pHi that would be
induced by the activation or inhibition of NBCe1 at basal pHi
should not be able to induce significant effects on ionic
currents. Please note that these recordings were performed in
the presence of an active NHE-1. It has been previously dem-
onstrated that exclusive inhibition of NHE-1 or NBC does not
affect basal pHi, as the sole participation of each of these
transporters should be sufficient to maintain basal pHi at a
relative constant level (Vandenberg et al., 1993). Further-
more, we have previously demonstrated that at basal pHi,
the activation of NBCe1 generates a 4-acetamido-4-
isothiocyanatostilbene-2,2′-disulphonic acid (SITS)-sensitive
anionic current in the absence of changes in pHi (Aiello et al.,
Figure 6
Dose-response curve of the effect of a-L3 and a-L4 on NBCe1 trans-
port activity. (A) Dose-response effect of a-L3 on NBC1 activity at the
following concentrations of the serum containing the antibodies
(dilution v/v): 1:5000 (n = 5), 1:1000 (n = 4), 1:800 (n = 5), 1:500
(n = 5), 1:400 (n = 4). Values were obtained at 14 min following
application of the K+ pulse. (B) Dose-response effect of a-L4 on
NBCe1 activity at the following concentrations of the serum contain-
ing the antibodies (dilution v/v): 1:2000 (n = 5), 1:1000 (n = 4),
1:800 (n = 4), 1:500 (n = 7), 1:400 (n = 4), 1:250 (n = 4). Values were
obtained at 14 min following application of the K+ pulse. As stated in
the text (not shown in the present Figure), the concentration of the
N-I serum used was 1:500 and the value of DpHi obtained was 0.18
6 0.01 (n = 5).
Figure 7
Effects of a-L3 and a-L4 on NBCe1 activity evaluated with the ammo-
nium pulse. (A) Superimposed representative recordings of pHi
obtained from myocytes exposed to an ammonium pulse in the
absence (N-I serum) or the presence of a-L3 (1:500) or a-L4 (1:500).
The experiments were performed in the continuous presence of
HOE642 in order to block NHE-1 activity. (B) Average JH calculated at
different pHi values in the absence (serum sham, 1:500, n = 5) and
presence of a-L3 (1:500, n = 5) or a-L4 (1:500, n = 6). *P < 0.05
significantly different from N-I serum.
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1998; Villa-Abrille et al., 2007). Together, these electrophysi-
ological data confirm the participation of eNBC in the normal
configuration of the AP waveform of cat ventricular myo-
cytes, as suggested in our previous work (Villa-Abrille et al.,
2007), and position the current generated by NBCe1 as the
main, and may be the only, component of the total anionic
current carried by eNBC in these cells.
Discussion and conclusions
Polyclonal antibodies are useful to detect proteins with low
expression levels as more antibodies can bind to a single
protein molecule, thus enhancing the detection signal. Poly-
clonal antibodies raised against recombinant peptides corre-
sponding to amino acid sequences of a protein have proven
to be useful not only in understanding the structure, and
molecular forms of AE1 and AE3 Cl-/HCO3- exchanger and
NBCe1, but also for studying functional aspects of the trans-
porters (Puceat et al., 1998; Khandoudi et al., 2001; Chiappe
de Cingolani et al., 2006). Here we generated polyclonal anti-
bodies against the putative third, EC3, and fourth, EC4, extra-
cellular loops of rat NBCe1. Target antigenic sequences
selected were predicted as flexible regions without b-sheet or
a-helix secondary structures, with at least 24% of one of the
following amino acids: R, N, Q, K, D or E, and presence of Y
and/or P amino acids conferring structural motif to the
antigen. The antigen-binding site of a typical antibody is a
cleft formed by folded variable heavy and variable light
regions. It can accommodate approximately four to seven
amino acids or sugar residues and such amino acid sequence
conformation is not preserved comparing the EC3 and EC4 of
NBCe1 and other bicarbonate transporters (Figure 1A). Nev-
ertheless, we were also able to confirm that a-L3 or a-L4 do
not recognize other NBC isoforms (NBCe2 or NBCn1,
Figure 2A).
Antibodies were able to detect NBCe1 on immunoblots
using cat cardiac ventricles or lysates of NBCe1-transfected
HEK293 cells (Figure 1). The antisera also detected the NBCe1
protein in immunoprecipitation experiments conducted in
cat and rat myocardium (not shown), demonstrating the role
of the antibodies when the native protein conformation
(denaturing conditions) was preserved. In addition, a-L3 and
a-L4 were helpful in studying the localization of NBCe1 in
isolated cardiomyocytes by immunocytochemistry, proving
the ability of the antibodies to recognize folded tertiary struc-
tures of the NBCe1 protein (Figure 3).
The NBC and the NHE are the main acid-extruders in
cardiac myocytes and contribute equally to the regulation of
basal pHi (Lagadic-Gossmann et al., 1992; Camilion de
Figure 8
Effects of a-L3 and a-L4 on NBCe1 activity, evaluated with perforated patches of cat isolated cardiomyocytes. (A) representative traces of action
potentials, recorded in HCO3- containing solution at constant pHo, before and after exposing the myocytes during 10 min to N-I serum, serum
containing a-L3 or serum containing a-L4. (B) Average effects of N-I serum (1:500, n = 6), a-L3 (1:500, n = 6) and a-L4 (1:500, n = 6) on APD90
expressed as % change relative to the control values. The data were obtained 10 min after the treatment with the respective sera. *P < 0.05
significantly different from N-I serum.
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Hurtado et al., 1995; Le Prigent et al., 1997; Vaughan-Jones
et al., 2006; 2009). The employment of several selective phar-
macological blockers of the NHE (Bountra and Vaughan-
Jones, 1989; Harrison et al., 1992; Scholz et al., 1993; Knight
et al., 2001) proved helpful in documenting the participation
of this transporter in cardiac physiology. Moreover, these
compounds were beneficial in different pathophysiological
settings, including ischaemia/reperfusion (Scholz et al., 1995;
Clements-Jewery et al., 2004) and myocardial hypertrophy
(Cingolani and Ennis, 2007). In contrast, the lack of specific
NBC blockers has made it difficult to investigate the contri-
bution of this bicarbonate transporter to cardiac physiology
and pathophysiology. Thus, it is important to mention the
availability of a new compound, S0859, which selectively
blocks NBC (Ch’en et al., 2008). This compound, however,
inhibited all cardiac NBC activity, making it a broad-spectrum
NBC inhibitor that is not NBC isoform selective (Ch’en et al.,
2008), as also recently demonstrated in cat ventricular myo-
cytes (De Giusti et al., 2009). Therefore, the ability of a-L3 to
block NBCe1 selectively, opens new and valuable paths to
dissect the specific NBCe1 activity.
The data presented in this work demonstrated that the
predominant electrogenic alkalinizing mechanism in cat ven-
tricular myocytes was NBCe1, suggesting that either NBCe2
was not expressed at all or it was expressed, but barely detect-
able in the potassium pulse. Although data supporting
expression of NBCe2 in the heart have been previously
reported (Pushkin et al., 2000; Virkki et al., 2002), the pres-
ence of this NBC isoform in myocardium has been ques-
tioned (Yamamoto et al., 2007). It is also possible, however,
that NBCe2 may be present in heart cells other than myo-
cytes, as it was suggested for NBCn1 in rat and mouse myo-
cardium (Damkier et al., 2006; Boedtkjer et al., 2008).
We have previously demonstrated in cat ventricular myo-
cytes that the bicarbonate-mediated and cariporide insensi-
tive pHi recovery from acidosis was totally blocked by SITS or
S0859, indicating that it is mediated by NBC (De Giusti et al.,
2009). As a-L3 reduced JH by approximately 50%, we speculate
that in cat ventricular myocytes, both isoforms, electroneu-
tral NBCn1 and electrogenic NBCe1, are functionally active,
exhibiting equivalent participation in the regulation of pHi.
However, we cannot rule out the possibility that the activity
of NBCe2 could be barely detectable with the potassium pulse
but could be more important during the recovery from aci-
dosis in the ammonium pulse. Thus, we cannot completely
exclude the participation of NBCe2 in the remaining recovery
from the acid load in the presence of a-L3.
If we consider that the main NBC isoforms of cardiac
myocytes are NBCe1 and NBCn1 and because NBCe1 medi-
ates the co-influx of 1 Na+ and two HCO3- ions, this trans-
porter would carry one third of the total Na+ loading induced
by the NBC-mediated HCO3- transport. Although intracellu-
lar Na+ (Na+i) measurements are needed to confirm this issue,
it is feasible to anticipate that the ‘Na+ sparing’ HCO3- flux
induced by NBCe1 would lead to less deleterious effects on
cardiomyocyte function in comparison with NBCn1 in some
enhanced Na+i scenarios, like that produced during pHi recov-
ery from acidosis upon reperfusion after ischaemia. Selective
blockade of NBCe1 during reperfusion after low-flow
ischaemia, however, induced almost complete recovery of
contractile parameters, in rat isolated perfused hearts
(Khandoudi et al., 2001). Further research is needed to give
clearer insights into this matter.
The idea that functional antibodies can be used as phar-
macological tools is not new (Haber, 1992). Antibodies that
produce loss of function (Puceat et al., 1998; Khandoudi et al.,
2001; Chiappe de Cingolani et al., 2006) or gain of function
(Borda et al., 1984; Magnusson et al., 1994) of targeted cardiac
proteins have been previously reported. As far as we can find,
this is the first study to identify antibodies directed against
different portions of the same cardiac protein that evoke
opposite effects on the function of the antigen. The investi-
gation of the possible mechanisms involved in the inhibition
and stimulation of NBCe1 by a-L3 and a-L4, respectively, did
not constitute an objective of the present work. On the basis
of the modular structure of sodium-coupled bicarbonate
transporters (Boron et al., 2009), some speculations about the
mechanistic action of these antibodies can be made. It is
well accepted that the anion blockers, stilbene-derived
SITS and 4,4′-diisothiocyanatostilbene-2,2′-disulphonic acid,
covalently couple to the first lysine in a KXXK motif at the
extracellular end of trans-membrane segment 5, which is
sequentially adjacent to EC3 of most bicarbonate transport-
ers, including all NBC isoforms (Boron et al., 2009). Previous
data (Khandoudi et al., 2001) and the present work show that
antibodies produced against EC3 block NBCe1 activity, which
lends support to the hypothesis that these antibodies inter-
fere with anion transport in a similar fashion to the stilbene
derivatives. Furthermore, a similar blocking effect of the
activity of the AE3 induced by a functional antibody directed
against the EC3 (but not against the EC4) has been previously
reported (Chiappe de Cingolani et al., 2006). Conversely, con-
formational changes of the transporter induced by a-L4 could
explain the stimulatory effect of this antibody on NBCe1
activity. These changes could favour dimerization of the
protein (Kao et al., 2008) or facilitate the interaction between
NBCe1 and the carbonic anhydrase (CA) (Alvarez et al.,
2003). However, at least for the interaction with CAIV, the
latter possibility seems unlikely because the binding site for
this CA is localized in the EC4 (Alvarez et al., 2003).
Evidence for a causal relationship between NBC and
cardiac pathophysiology are still lacking. NBC is, however,
activated during reperfusion after ischaemia (Schafer et al.,
2000; Doggrell and Hancox, 2003; van Borren et al., 2004;
Ten Hove et al., 2005) and the damage produced by this
pathology can be attenuated by blockade of this transporter
(Khandoudi et al., 2001), suggesting that NBCe1 activity
could be harmful in this setting. In addition, up-regulation of
the expression of NBC in hearts of patients with heart failure
(Khandoudi et al., 2001) and in hearts of infarcted animals
(Sandmann et al., 2001) has been also reported. More
recently, expression of NBCe1 and NBCn1 in hypertrophic rat
hearts was reported (Yamamoto et al., 2007). As corroborated
herein, NBCe1 produces an anionic repolarizing current,
which would attenuate the characteristic prolongation of
APD present in cardiac hypertrophy (Carmeliet, 2006),
opening the question of whether NBCe1 up-regulation would
be compensatory and beneficial, or deleterious. Thus, the
selective opposing effects of a-L3 and a-L4 on NBCe1 function
may provide insight into the possibility that NBCe1 activity
could be a ‘friend or foe’ depending on the cardiac pathologi-
cal state studied.
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Supporting information
Additional Supporting information may be found in the
online version of this article:
Figure S1 Measurement of the bi. bi of the myocytes was
measured by exposing cells to varying concentrations of
NH4Cl in Na+-free HEPES bathing solution. pHi was allowed to
stabilize in Na+-free solution before application of NH4Cl. bi
was calculated from the equation bi = D[NH4+]i/DpHi and
referred to the mid-point values of the measured changes in
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pHi. bi at different levels of pHi was estimated from the least
squares regression lines bi versus pHi plots. Na+-free HEPES
bathing solution (in mmol·L-1): HEPES 25, KCl 4.66, MgSO4
1.05, CaCl2 1.35, N-methyl-D-glucamine 148, glucose 11 and
NH4Cl 0, 3, 5, 9, 12, 15 or 20, pH adjusted to 7.4 with HCl.
The figure shows the bi versus pHi plot and the regression line
used to fit it (n = 8).
Figure S2 Specificity of the potassium pulse to evaluate
eNBC activity. Average data of the increase in pHi obtained
after 14 min of exposure of the myoctes to high K+ in the
absence of bicarbonate (0 HCO3-, n = 6) or sodium (0 Na+, n =
4).* indicates P < 0.05 versus control.
Figure S3 Specific action of a-L4 on NBCe1 evaluated in the
potassium pulse. Average data of the increase in pHi obtained
after 14 min of exposure of the myocytes to high K+ in the
presence of the N-I serum (n = 5) or in the continuous pres-
ence of a-L4 co-incubated with S0859 (n = 4) or in the absence
of bicarbonate (n = 3) or sodium (n = 4). * indicates P < 0.05
versus N-I serum.
Figure S4 Specific action of a-L3 and a-L4 evaluated in the
ammonium pulse in 0 HCO3-. Average JH calculated at pHi 6.8
in the absence (N-I serum, 1:500, n = 4) and presence of a-L3
(1:500, n = 3) or a-L4 (1:500, n = 4). These experiments were
performed in the absence of bicarbonate (HEPES-buffered
solution) and in the absence of the NHE-1 inhibitor, HOE642.
Under these conditions, the only active alkalinizing mecha-
nism is the NHE-1.
Figure S5 No effects of a-L3 and a-L4 on APD in the absence
of HCO3-. Representative traces of action potentials recorded
in extracellular solution without HCO3- (HEPES-buffered
solution). The traces were recorded before and after 10 min of
exposing the myocytes to serum, containing a-L3 (1:500) or
serum containing a-L4 (1:500). As observed, no effects of the
antibodies were observed under these conditions. On
average, the percentage effects relative to control on APD50
were –0.516 1.24% (n = 5) and 0.286 1.51% (n = 5) with a-L3
and a-L4 respectively. The percentage effects relative to
control on APD90 were –0.22 6 0.85% (n = 5) and –0.32 6
1.51% (n = 5) with a-L3 and a-L4 respectively.
Please note: Wiley-Blackwell are not responsible for the
content or functionality of any supporting materials supplied
by the authors. Any queries (other than missing material)
should be directed to the corresponding author for the article.
BJPFunctional antibodies against NBCe1
British Journal of Pharmacology (2011) 164 1976–1989 1989
